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Genomic abnormalities are often seen in tumor cells,
and tetraploidization, which results from failures
during cytokinesis, is presumed to be an early step
in cancer formation. Here, we report a cell division
control mechanism that prevents tetraploidization
in human cells with perturbed chromosome segrega-
tion. First, we found that Aurora B inactivation
promotes completion of cytokinesis by abscission.
Chromosome bridges sustained Aurora B activity to
posttelophase stages and thereby delayed abscis-
sion at stabilized intercellular canals. This was
essential to suppress tetraploidization by furrow
regression in a pathway further involving the phos-
phorylation of mitotic kinesin-like protein 1 (Mklp1).
We propose that Aurora B is part of a sensor that
responds to unsegregated chromatin at the cleavage
site. Our study provides evidence that in human cells
abscission is coordinated with the completion of
chromosome segregation to protect against tetra-
ploidization by furrow regression.
INTRODUCTION
Failures in cytokinesis can lead to tetraploidy (Caldwell et al.,
2007; Fujiwara et al., 2005; Ganem et al., 2007; Uetake and
Sluder, 2004), a state that has for a long time been suspected
to contribute to cancer formation (Caldwell et al., 2007; Ganem
et al., 2007), as recently demonstrated in a mouse model (Fuji-
wara et al., 2005). Faithful cytokinesis requires tight coordina-
tion with chromosome segregation (Eggert et al., 2006; Glotzer,
2005). Specifically, the completion of cytokinesis by abscission
needs to await complete clearance of chromatin from the
cleavage plane. While chromosome segregation normally
completes early after anaphase onset, it can be severely
delayed by lagging or bridged chromosomes. Such segregation
defects have been estimated to occur in about 1% of dividing
somatic cells, and at higher incidence in transformed cells
(Cimini et al., 2003; Gisselsson et al., 2000). Chromosome
bridges can result from dysfunctional telomeres (Maser and
DePinho, 2002; Stewenius et al., 2005), DNA double-strand
breaks (Acilan et al., 2007), or from misregulated chromosomecohesion (Chestukhin et al., 2003; Cimini et al., 2003) or deca-
tenation (Chan et al., 2007). It is unclear how cells respond to
chromosome bridges (Ganem et al., 2007; Mullins and Biesele,
1977; Weaver et al., 2006), and if any control mechanisms
would ensure faithful abscission in the presence of chromo-
some bridges.
The regulation of abscission timing in animal cells is poorly
defined, but may be related to a recently discovered pathway
in budding yeast, termed NoCut (Norden et al., 2006). As part
of this pathway, aurora kinase Ipl1 delays abscission in response
to midspindle defects, which led to the hypothesis that it could
monitor the completion of chromosome segregation for the
control of abscission timing. It is not known if abscission timing
is regulated at this level in higher eukaryotes.
The vertebrate homolog of Ipl1, Aurora B, is essential for
mitosis and cytokinesis (Eggert et al., 2006; Ruchaud et al.,
2007). Aurora B-dependent pathways regulating furrow ingres-
sion are well established. This includes Aurora B-dependent
phosphorylation of mitotic kinesin-like protein 1 (Mklp1) (Guse
et al., 2005; Neef et al., 2006). Following furrow ingression,
Aurora B localizes to the midbody (Ruchaud et al., 2007), but
its potential regulation of abscission timing has not been investi-
gated. Mklp1 also localizes to the midbody (Guse et al., 2005;
Neef et al., 2006), raising the possibility that Aurora B could
regulate furrow ingression and abscission through common
downstream effectors.
Aurora B is regulated at many levels (Ruchaud et al., 2007).
To become active, it requires association with its coactivator
INCENP. Its activity further depends on autophosphorylation at
a threonine 232 residue in its activation loop (Yasui et al.,
2004), and as part of the chromosome passenger complex, it
needs to be targeted to distinct subcellular locations during
mitotic progression.
Here, we established in vivo assays to investigate the regu-
lation of abscission timing in human cells, and its coordination
with the completion of chromosome segregation. We found
that Aurora B inactivation at the midbody promotes abscission.
Chromosome bridges delayed abscission and sustained
Aurora B activity to posttelophase, which was essential to
stabilize Mklp1 at the intercellular canal and to suppress furrow
regression. Based on these data, we propose that Aurora B
functions as part of a sensor that responds to unsegregated
chromatin in the cleavage plane to control abscission timing
and to protect missegregating cells against tetraploidization
by furrow regression.Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc. 473
RESULTS
Chromatin Localized to the Cleavage Plane Can Lead
to Spontaneous Furrow Regression
Previous studies reached controversial conclusions to which
extent chromosome bridges cause tetraploidization by cytoki-
nesis failure (Mullins andBiesele, 1977; Shi andKing, 2005; Stew-
enius et al., 2005;Weaver et al., 2006). Because this could be due
to the difficulty to reliably detect thin chromosome bridges by
conventional wide field microscopy, we applied high resolution
3-D confocal time-lapse microscopy to monitor chromosome
segregation and cleavage furrow ingression/regression in live
cells. UsingaHeLacell line stably coexpressingmarkers for chro-
matin (H2B-mRFP [Keppler et al., 2006]), and plasmamembrane
(MyrPalm-mEGFP [Zacharias et al., 2002]), we found that cytoki-
netic furrow ingression always completed within 20 min after
anaphase onset (n = 774), both in cells without chromosome
bridges (n = 728), as well as in all cells with chromosome bridges
(n = 46). Subsequent furrow regression occurred exclusively in
cellswith chromosomebridges (n = 16out of 774 imageddividing
cells; Figure 1A and Movie S1 available with this article online).
The sensitivity for bridge detection was validated by counter-
stainingwith Hoechst (100%ofHoechst bridgeswere detectable
by H2B-mRFP; n = 43; data not shown). These observations
support the hypothesis that chromatin trapped in the cleavage
plane is amain cause for spontaneous cytokinesis failure in tissue
culture cells (Mullins and Biesele, 1977; Stewenius et al., 2005;
Weaver et al., 2006). To compare the incidence of furrow regres-
sion inmissegregating cells to the overall rate of tetraploidization,
we next assayed the other known mechanisms that can lead to
tetraploidization (Ganem et al., 2007). First, we assayed in the
same dataset cell-to-cell fusion to neighboring nonsister cells,
and spontaneous mitotic slippage (mitotic exit without chromo-
some segregation and cytokinesis; see Figure S1A). Neither
process ever occurred in the movies of 774 dividing cells,
indicating that these events must be extremely rare. Next, we
probed for endoreplication (multiple rounds of replicationwithout
intermediate mitosis). By long-term confocal time-lapse imaging
of HeLa cells stably expressing H2B-mRFP and the replication
factory marker mEGFP-PCNA (Leonhardt et al., 2000), we found
that cells always progressed from early to late S-phase replica-
tion foci patterns and subsequently entered mitosis, never
entering a second S-phase without preceding mitosis (n = 173;
assay shown in Figure S1B). Thus, spontaneous endoreplication
must also be extremely rare, if present at all in HeLa cells. Finally,
multinucleate cells always had thin DNA threads coated by the
inner nuclear envelope marker LAP2 connecting their individual
nuclei (Figure S1C; n = 20). This is consistent with their origin
from furrow regression after chromosome bridging, but would
not be expected to result from any other known process leading
to tetraploidization. Together, our data suggest that furrow
regression in response to chromosomebridges is themain cause
for tetraploidization in HeLa cells.
Cells with Chromosome Bridges Proliferate Normally
Unless They Regress the Cleavage Furrow
Consistent with previous studies (Fujiwara et al., 2005; Ganem
et al., 2007; Shi and King, 2005), we found by long-term474 Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc.imaging of HeLa cells stably expressing H2B-mRFP over
80 hr that cells that regressed the furrow frequently entered
abnormal mitosis, which impaired their proliferation (Figures
1B, 1D, 1E, and S1D, and Movies S2 and S4). Remarkably,
the majority of cells with chromosome bridges (71%; n = 143)
did not regress the furrow and proliferated at rates close to nor-
mally segregating cells (Figures 1C, 1D, and 1E, and Movies S3
and S4). We thus asked if chromosome bridges resolve shortly
after anaphase onset to allow unperturbed abscission. Gradual
thinning of chromosome bridges during mitotic exit limits their
detection by time-lapse imaging of chromatin markers.
However, the inner nuclear envelope marker EGFP-LAP2b
(Muhlhausser and Kutay, 2007), which localized around chro-
matin from late anaphase on (Figure 2A and Movie S5), effi-
ciently visualized chromosome bridges during subsequent cell
cycle stages (LAP2b-bridges always correlated with chromo-
some bridges in high resolution still images; n = 10; Figure 2B).
By time-lapse imaging, we found that the majority of chromo-
some bridges persisted long into interphase (76% for more
than 5 hr; n = 46). The relatively low incidence of cleavage
furrow regression is surprising with respect to the persistence
of chromosome bridges, and could be due to a mechanism
that delays abscission until eventual resolution of chromosome
bridges.
Chromosome Bridges Delay Abscission
To address if chromosome bridges were correlated with delayed
abscission, we probed for cytoplasmic continuity of postmitotic
sister cells. HeLa cells expressing H2B-mCherry were scored for
chromosome bridges during anaphase and then followed into
interphase. A coexpressed photoactivatable GFP (PAGFP [Pat-
terson and Lippincott-Schwartz, 2002]) was then photoactivated
in one sister cell. Any subsequent increase of PAGFP fluores-
cence in the nonactivated sister cell reports on diffusion between
the two cells, indicating that abscission had not taken place.
While all normally segregating sister cells had undergone abscis-
sion 180 min after anaphase onset (n = 25 pairs of sister cells;
Figure 2C), the majority of chromosome bridge-containing sister
cells (86%, n = 29; Figure 2D) at that time were still connected by
cytoplasmic canals that allowed PAGFP diffusion into the nonac-
tivated sister cell. To test if in these cells abscission can occur at
later interphase stages, we combined long-term time-lapse
imaging of mRFP-LAP2b with the PAGFP assay (Figure S2). All
cells that resolved the chromosome bridge had abscised prior
to photoactivation (n = 14). In contrast, only a single out of 21
pairs of sister cells with intact chromosome bridges failed to
exchange PAGFP. Together, these data demonstrate that chro-
mosome bridges delay abscission.
Removal ofChromosomeBridges by LaserMicrosurgery
Leads to Abscission
To test if resolution of chromosome bridges directly leads to
abscission, we established a protocol to remove chromosome
bridges from the abscission site by intracellular laser microsur-
gery. Using HeLa cells stably coexpressing mRFP-LAP2b and
MyrPalm-mEGFP as markers for the chromosome bridge and
the plasma membrane, we first validated that laser cutting of
the chromosome bridge at cytoplasmic regions close to the
nucleus (minimum distance from ingressed furrow 1.3 mm; mean
distance 2.9 mm) did not affect the overall integrity of the sister
cells (n = 9; Figure 2E). Next, we cut the chromosome bridge in
cells stably coexpressing mRFP-LAP2b and PAGFP. In 6 out of
12 cells this led to complete removal of the bridge from the cyto-
Figure 1. Effect of Chromosome Bridges on
Abscission and Proliferation
(A) Chromosome bridge (0:00; open arrowhead)
preceding cleavage furrow regression (14:53; arrow-
heads) in HeLa cell stably expressing markers for
chromatin (H2B-mRFP) and plasma membrane
(MyrPalm-mEGFP).
(B–E) Clonal proliferation studied by long-term
imaging of H2B-mRFP expressing cells. (B) Chromo-
some bridge-containing cell (0:00; open arrowhead)
whose daughter cells subsequently assembled
a common metaphase plate (19:51; 20:26). This indi-
cates cleavage furrow regression prior tomitotic entry,
as validated in an independent experiment (see
Figure S1D). (C) Chromosome bridge-containing cell
(0:00; arrowhead), whose daughter cells enter the
following mitosis separately (no cleavage furrow
regression). Cell lineage was tracked according to
arrowhead colors. (D) Clonal proliferation of control
cells and cells with chromosome bridges. Lineages
were manually tracked over time. (E) Quantitation of
clonal proliferation as in (D).
Data are mean ± SD; n = 10 colonies per condition.
Scale bars represent 10 mm.
plasmic canal connecting the sister cells
(Figure 2F). By subsequent photoactivation
of PAGFP in one sister cell and time-lapse
imaging over 65 min we found that all cells
with removed chromosome bridges had
undergone abscission. This was unlikely
due to simple mechanical separation of the
entire sister cells by the laser cutting proce-
dure, as the cutting path was at least 1.5 mm
(mean distance 2.7 mm) displaced from the
ingressed furrow, similar to the experiment
shown in Figure 2E, which did not show
any detectable changes in the morphology
of the plasma membranes between sister
cells 2 min (Figure 2E), as well as 30 min
(data not shown) after laser microsurgery.
To further test for the specificity of abscis-
sion in response to removal of the chromo-
some bridge, rather than potential unrelated
cellular damage by the laser cutting proce-
dure, we applied the same protocol with
the laser cutting path slightly displaced
from the chromosome bridge (Figure 2G).
Only one out of 11 cells treated by this
control procedure underwent abscission
after laser microsurgery, as scored by the
PAGFP assay. To exclude the possibility
that the slightly different orientation of the
laser cutting path relative to the abscission
site affected the outcome of this experiment, we also tested if
laser microsurgery would lead to abscission in telophase cells
(Figure 2H). The cutting path was similar to that applied in cells
with chromosomal bridges, with a minimum distance of 1.2 mm
(mean distance 2.1 mm) from the ingressed furrow. In 12 outCell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc. 475
Figure 2. Chromosome Bridges Persist after Mitotic Exit and Delay Abscission
(A) Nuclear envelope assembly around chromosome bridge during late anaphase in HeLa cell expressing H2B-mRFP and EGFP-LAP2b. Open arrowhead at 0min
indicates chromosome bridge during early anaphase. Closed arrowhead at 628 min indicates chromosome bridge during interphase.
(B) Interphase LAP2b bridges contain chromatin. HeLa cells expressing mRFP-LAP2b were stained with Hoechst. Cells were synchronized to 15 hr after mitotic
shake-off.
(C and D) Chromosome bridges delay abscission. Chromosome bridges were scored in HeLa cells stably expressing H2B-mCherry, and cells were followed by
time-lapse imaging. Abscission was probed by photoactivation of PAGFP in one sister cell (dashed circles), and detection of PAGFP fluorescence approximately
2 hr later in the nonactivated sister cells (solid circles). (C) A normally segregating control cell showed no detectable PAGFP fluorescence in the nonactivated
sister cell (275 min; solid circle), which indicates that abscission had taken place. (D) A cell containing a chromosome bridge (open arrowhead) showed PAGFP
fluorescence in the nonactivated sister cell (283 min; solid circle), and had thus not abscised.
(E) Removal of the chromosome bridge by laser microsurgery (along the yellow line) does not perturb normal cell membrane morphology, as visualized in HeLa
cells stably expressing MyrPalm-mEGFP and mRFP-LAP2b.
(F and G) Removal of chromosome bridge from the cleavage site leads to abscission. Chromosome bridges (arrowheads) were visualized in HeLa cells stably ex-
pressing mRFP-LAP2b and PAGFP. Laser microsurgery was close to the nucleus of one sister cell as indicated by yellow lines. Photoactivation of PAGFP in one
sister cell was 5 min after laser cutting and was repeated in 10 min intervals during subsequent time-lapse imaging. (F) Removal of the bridge (5 min; open arrow-
heads mark tips after cutting) led to abscission (70 min), (G) Cutting at cytoplasmic regions adjacent to the chromatin bridge did not lead to abscission (63 min).476 Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc.
of 13 pairs of sister cells, PAGFP still exchanged 10 min after
laser microsurgery, demonstrating that the laser microsurgery
procedure per se does not cause abscission. We conclude
that removal of chromatin from the cleavage plane leads to
abscission.
Conversion ofMidbodies into Stable Intercellular Canals
The ingressed cleavage furrow is normally anchored at the mid-
body. The disassembly of midbody microtubule bundles
defines the end of telophase, which normally coincides with
abscission (see below). Midbody disassembly proceeds by
sequential disassembly of microtubule bundles on either side
of a central midbody region, which subsequently persists as
a midbody remnant (Figures S3A and S3B). We were thus
surprised to note that despite of the abscission delay, chromo-
some bridge-containing HeLa cells disassembled midbody
microtubule bundles already 60 ± 9 min (mean ± SD; n = 19;
Figure 3A and Movie S6) after furrow ingression, similar to nor-
mally segregating cells (60 ± 10 min; n = 12; Figure S3B and
Movie S7). To investigate if other cytoskeletal structures could
contribute to the stabilization of intercellular canals in cells with
chromosome bridges, we visualized actin in vivo using a HeLa
cell line stably coexpressing actin-EGFP and H2B-mRFP. We
found that in normally segregating cells actin enriched at the
ingressing cleavage furrow, where it remained until 61 ± 11 min
(n = 12; Figure S3C and Movie S8). The disappearance of actin-
EGFP accumulations from the ingressed furrow thus correlated
with the time of midbody microtubule disassembly and abscis-
sion (compare with Figures S3C, 5E, and 5F). Cells containing
chromosome bridges did not disassemble actin-EGFP at that
time, but instead accumulated actin-EGFP at two prominent
patches on either side of the cytoplasmic canal (Figure 3B,
Movie S9; patches detected in 90% of chromosome bridge-
containing cells; n = 166; never in cells without chromosome
bridges; n = 45). Actin patches could also be visualized by
phalloidin (Figure S3D) and remained stable throughout inter-
phase (Figure S3E and Movie S10), and disappeared only
when chromosome bridges resolved (Figures 3C, S3F, and
Movie S11; n = 18), or the cleavage furrow regressed
(Figure 3D and Movie S12; n = 46). Thus, missegregating cells
delay abscission at stable actin-rich canals.
Mechanical Barriers Do Not Induce Stable
Intercellular Canals
Abscission delay and assembly of stable intercellular canals
induced by chromosome bridges could be a constitutive
cellular response to the presence of a mechanical barrier. Alter-
natively, it could specifically depend on the presence of chro-
matin at the cleavage site. To discriminate between these
possibilities, we introduced mechanical barriers at the cleavage
site that did not contain chromatin. Asbestos fibers, which have
similar dimensions as chromosome bridges (Fig. S4A, B), effi-
ciently incorporate into dividing cells (Jensen et al., 1996).Localization of asbestos fibers to cytoplasmic regions close
to the ingressing cleavage furrow did not perturb furrow ingres-
sion (n = 84; Figure 4A and Movie S13) and midbody assembly
(n = 23; Figure 4B). Cells with asbestos fibers at the ingressed
furrow never contained actin accumulations at the intercellular
canal (Figure 4C; n = 13; compare Figure S3D), and frequently
regressed the furrow very early after telophase (62% within 3 hr
after furrow ingression; n = 84; detected by confocal time-lapse
imaging; Figure 4A and Movie S13). However, furrow regres-
sion never occurred when intracellular asbestos fibers were
not trapped by the ingressed furrow (n = 42; Figure S4C),
demonstrating that rapid furrow regression depended on the
specific localization of asbestos fibers. Together, these data
indicate that mechanical blockage at the abscission site is
not sufficient to sustain a stable intercellular canal.
Aurora B Controls Abscission Timing
The regulation of abscission timing in animal cells is unknown,
but in S. cerevisiae depends on the inactivation of the aurora
kinase Ipl1 (Norden et al., 2006).We thus investigated if this func-
tion is conserved in the mammalian Ipl1 homolog, Aurora B.
Aurora B did not change its localization upon midbody micro-
tubule disassembly (Figure S5A), which normally coincides with
abscission (see below). It persisted at high levels on the mid-
body remnant, a structure that becomes visible after abscis-
sion (detected on midbody remnant by immunofluorescence
in 49/50 cells; Figures 5A and 5B; by time-lapse imaging of
Aurora B-EGFP during midbody disassembly; Figure S5A). It
is therefore unlikely that sub-cellular localization changes or
degradation of Aurora B contribute to abscission control.
Aurora B activity depends on phosphorylation of a T232
residue (Yasui et al., 2004). Using an antibody specifically
recognizing phospho-T232-Aurora B, we found midbody-local-
ized Aurora B always highly phosphorylated (n = 20;
Figure 5C), suggesting that Aurora B remains active throughout
entire telophase. The antibody was specific, as inhibition of
Aurora B by ZM1 (Girdler et al., 2006) removed all detectable
phospho-T232 Aurora B from late midbodies (Fig. S5B-C).
Midbody remnants never contained significant amounts of
phospho-T232-Aurora B (0.8 ± 1.3% of telophase levels; n =
20; Figure 5D). The correlation of Aurora B dephosphorylation
with midbody microtubule disassembly suggests that Aurora B
inactivation may provide a trigger for abscission. To directly
test this, we examined the effect of premature Aurora B inac-
tivation during telophase in HeLa cells stably coexpressing
mCherry-a-tubulin and PAGFP. By repetitive photoactivation
of PAGFP in one postmitotic sister cell, and measuring
increase of fluorescence in the other sister cell over time, we
determined the precise timing of abscission (Figures 5E–5G,
and Movie S14). In normally segregating HeLa cells abscission
occurred 60 ± 10 min (mean ± SD; n = 12) after complete
cleavage furrow ingression. This coincided with disassembly
of midbody microtubule bundles (60 ± 9 min; mean ± SD;(H) Laser microsurgery at the midbody does not induce abscission. Laser microsurgery (along the yellow line) was applied to telophase HeLa cells stably coex-
pressingmCherry-a-tubulin andPAGFP. Ablation of one side of themidbodywith identical settings as in the experiments shown in (E–G) did not induce abscission
10 min after microsurgery.
Scale bars represent 10 mm.Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc. 477
Figure 3. Delayed Abscission Occurs at Stable Actin-Rich Intercellular Canals
(A) Normal midbody microtubule disassembly (arrowhead; 63:57) in HeLa cell stably expressing mEGFP-a-tubulin and H2B-mRFP with chromosome bridge
(open arrowhead; 4:45).
(B) Assembly of actin patches (arrowheads, 123:50; 178:00) in HeLa cell stably expressing H2B-mCherry and actin-EGFP containing chromosome bridge (open
arrowhead; 7:44).
(C) Actin patches disassemble when chromosome bridges resolve (2:05 - 2:37; arrowheads). Time-lapse recording of a HeLa cell expressing mRFP-LAP2b and
actin-EGFP.
(D) Disassembly of actin-patches during furrow regression (2:47). HeLa cells stably expressing H2B-mCherry and actin-EGFP were scored for chromosome
bridges during anaphase. Dashed lines indicate the position of the ingressed furrow.
Scale bars represent 10 mm.n = 19). When cells that had completed furrow ingression were
treated with the Aurora kinase inhibitor Hesperadin (Hauf et al.,
2003), they abscised significantly earlier (44 ± 7 min; mean ±
SD; n = 14; 2-tailed Mann-Whitney U-test at a = 0.01; p <
0.001; Figure 5G), again coincident with premature midbody
microtubule disassembly (41 ± 6; mean ± SD; n = 30; p <
0.001). Similar data were obtained with a different Aurora B
inhibitor, ZM1 (Girdler et al., 2006) (Figure 5G), and in normal
rat kidney (NRK), and in noncancer human retinal pigment
epithelial (hTERT-RPE1) cells (Figure 5H), in which the expres-
sion levels of Aurora B were similar to HeLa cells (Figure S6E).
We conclude that Aurora B inactivation promotes abscission in
animal cells.478 Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc.Chromosome Bridges Sustain Aurora B Activity
to Posttelophase Stages
To test if Aurora B could also control delayed abscission in mis-
segregating cells, we investigated its localization and activity by
immunofluorescence in HeLa cells with chromosome bridges
synchronized to 3 hr after mitotic shake-off. We staged cells as
posttelophase based on disassembled midbody microtubule
bundles (see above). Aurora B localized to a single narrow ring
at the site where the chromosome bridge passed through the
ingressed furrow (n = 35; Figures 6A and 6D;Movie S15). In these
rings, Aurora B was highly phosphorylated at T232 (n = 21;
Figure 6B), in contrast to midbody remnants in posttelophase
cells without chromosome bridges (see above and compare
Figure 5D). High levels of T232 phosphorylation were also
detected at chromosome bridges in 39 out of 40 unsynchronized
interphase cells, indicating that Aurora B also remains phosphor-
ylated throughout later stages of interphase in cells with chromo-
some bridges. Phosphorylated T232-Aurora B was also present
at rings around interphase chromosome bridges in NRK and
hTERT-RPE1 cells (Figures S6A and S6B). The Aurora B coacti-
vator INCENP also localized at rings around interphase chromo-
some bridges (n = 19 of 20 cells; Figure 6C).
Inhibition of Aurora B by ZM1 reduced the levels of T232 phos-
phorylation at chromosome bridges in HeLa cells to 48 ± 34%
(n = 25; synchronized to 3 hr postmitotic shake-off). Because
the phospho-T232 antibody did not cross-react at detectable
levels with unphosphorylated Aurora B during telophase
(compare Figures S5B and S5C), this suggests that at interphase
rings in cells with chromosome bridges, phospho-T232 did not
exclusively depend on Aurora B autophosphorylation. Together,
these data indicate that chromosome bridges sustain Aurora B
activity to posttelophase stages.
We next addressed the dynamics of Aurora Bwithin the ring by
fluorescence recovery after photobleaching (FRAP) in HeLa cells
expressingmRFP-LAP2b and EGFP-tagged Aurora B (Yan et al.,
2005). Aurora B-EGFP fluorescence recovered to 32 ± 9%
(mean ±SEM; n = 7) within 45min after complete photobleaching
of the ring (Figures 6E and 6F), indicating that Aurora B bound
dynamically to the ring and constantly exchanged with the cyto-
Figure 4. Mechanical Barriers to Abscission
Do Not Stabilize Intercellular Canals after
Telophase
(A) Asbestos fibers (arrowheads) do not interfere
with furrow ingression and anchoring during telo-
phase (0 - 45 min), but lead to furrow regression
during interphase (open arrowheads; 53 min)
in HeLa cells stably expressing H2B-mRFP and
MyrPalm-mEGFP.
(B) Midbody morphology is unaffected by
asbestos fiber (arrowhead) passing through the
ingressed furrow in a cell stably expressing
mRFP-atubulin.
(C) Asbestos fibers (arrowhead) do not induce
actin patches at the intercellular canal in inter-
phase HeLa cells. Actin was visualized by Phalloi-
din staining in fixed cells (compare Figure S3D).
Scale bars represent 10 mm.
plasm. To probe if it could gain access to
chromatin inside of the nuclear envelope,
wenext investigated nuclear-cytoplasmic
shuttling of Aurora B-EGFP in interphase
HeLa cells stably coexpressing Aurora
B-EGFP and H2B-mCherry. For this, we
repetitively photobleached at a cyto-
plasmic region and probed for changes
of fluorescence intensity inside the
nucleus (Figure 6G). As cytoplasmic pho-
tobleaching rapidly depleted nuclear fluo-
rescence of Aurora B-EGFP (n = 7;
Figure 6H), we conclude that Aurora B can efficiently cross the
nuclear envelope.
Aurora B Protects Missegregating Cells against
Cleavage Furrow Regression
We next examined the function of prolonged Aurora B activity in
cells with chromosome bridges. One possibility is that premature
inactivation of Aurora B could induce abscission followed by
cutting of the chromosome bridge and DNA damage, similar to
the phenotype observed in Ipl1 deficient budding yeast (Norden
et al., 2006). Alternatively, the cytokinetic machinery in animal
cells might not be able to cut through chromosome bridges. If
this was the case, prematurely triggered abscission could fail
and lead to in increased rates of cleavage furrow regression.
We therefore tested if Aurora B inhibition in missegregating
cells promoted cutting through chromosome bridges or furrow
regression. Aurora B inhibition had no influence on the incidence
of chromosome bridge resolution during 14 hr time-lapse
imaging of HeLa cells stably coexpressing EGFP-LAP2b and
H2B-mRFP (19% in control, n = 36; 15% in Hesperadin or
ZM1-treated cells, n = 27). In contrast, Aurora B inhibition after
complete furrow ingression significantly (Fisher’s exact test at
a = 0.01; p < 0.001) raised the incidence of cleavage furrow
regression in chromosome bridge-containing cells from 33% in
control cells (n = 98) to 81% in cells treated with Hesperadin
(n = 79), and 66% in ZM1 treated cells (n = 53; Figure 6I). With
76% of anaphase chromosome bridges persisting throughoutCell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc. 479
interphase (as shown above; Figure 2A) these data indicate that
most if not all cells with persistent chromosome bridges undergo
cleavage furrow regression upon Aurora B inhibition. This cannot
be due to a general unspecific cellular response to kinase inhib-
itors, as neither Cdk1, nor MAPK inhibition during telophase
significantly changed the incidence of furrow regression in cells
with chromosome bridges: 31%, n = 35 after Cdk1 inhibition by
RO-3306; 38%, n = 47 after MAPK inhibition by SB203580 (p >
0.1 for both conditions compared to control, tested by Fisher’s
exact test). Importantly, Aurora B inhibition after complete furrow
ingression never induced furrow regression in normally segre-
Figure 5. Aurora B Controls Abscission
Timing
(A–D) Immunofluorescence in HeLa cells stably
expressing mRFP-a-tubulin to visualize the telo-
phase midbody (open arrowheads in [A] and [C]),
and the midbody remnant after abscission (open
arrowheads in [B] and [D]). Cells did not contain
chromosome bridges, as validated by an antibody
against LAP2. Antibodies against Aurora B, and
phospho-T232-Aurora B were as indicated in the
individual panels. Scale bars represent 10 mm.
(E and F) Assay for abscission timing. (E) Abscis-
sion timing probed by repetitive photoactivation
of PAGFP in region marked by dashed circle in
a HeLa cell expressing mCherry-a-tubulin and
PAGFP. Arrowhead indicates onset of midbody
microtubule disassembly (t = 0:00). Scale bars
represent 5 mm. (F) Mean PAGFP fluorescence
was measured in both sister cells as indicated by
solid circles in (E). Abscission was determined by
the stop in fluorescence increase in the nonacti-
vated sister cell (0:00).
(G) Timing from complete furrow ingression until
midbody microtubule disassembly and abscission
wasmeasured by the assays depicted in (E and F).
Cells were treated after complete furrow ingres-
sion with Hesperadin, ZM1, or DMSO for control.
(H) Timing from midbody formation until midbody
microtubule disassembly in NRK and hTERT-
RPE1 cells.
Bars represent mean of at least three experiments,
error bars indicate SD, * indicates significant
differences to control tested by 2-tailed Mann-
Whitney U-test at a = 0.01.
gating cells (n = 50). This demonstrates
that after complete furrow ingression
Aurora B has for main function to prevent
cleavage furrow regression in cells with
chromosome bridges.
Aurora B Phosphorylates and
StabilizesMklp1 at the Intercellular
Canal
A key requirement to prevent cleavage
furrow regression is the maintenance of
a cortically anchored furrow at a stable
intercellular canal. Mklp1 has been
proposed as such an anchoring factor
during telophase (Guse et al., 2005; Neef et al., 2006). We thus
addressed its role in interphase cells with chromosome bridges.
Using immunofluorescence on HeLa cells synchronized to 3 hr
after mitotic shake-off, we found Mklp1 localized to a narrow
ring at the cytoplasmic canal connecting chromosome bridge-
containing sister cells, similar to Aurora B (n = 36; Figure 7A;
compare Figure 6A). Using a phospho-specific antibody (Neef
et al., 2006), we found Mklp1 in these rings phosphorylated at
a S911 residue (n = 11 for HeLa cells; Figure 7A; for hTERT-
RPE1 and NRK cells see Fig. S6C, D). Inhibition of Aurora B by
ZM1 in chromosome bridge-containing HeLa cells after480 Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc.
complete furrow ingression reduced phospho-S911 levels at the
ring to 3.8 ± 4.4% (n = 11; Figure 7B). Aurora B inhibition also led
to gradual loss of Mklp1 from the ring around chromosome
bridges, which we quantitated in time-lapse movies of cells
coexpressing Mklp1-YFP and H2B-mRFP (n = 15; Figures 7C
and 7D). Together, these data establish Mklp1 as a prime down-
stream effector candidate of Aurora B for stabilization of the
Figure 6. In Posttelophase Cells with Chro-
mosome Bridges, Aurora B Remains Active
to Protect against Tetraploidization by
Furrow Regression
(A–C) Immunofluorescence stainings of HeLa cells
stably expressing mRFP-a-tubulin. Chromosome
bridges were detected by an antibody against
LAP2. Staining with antibodies against Aurora B
(A), phospho-T232 Aurora B (B), and INCENP (C).
Arrowheads mark the site where the LAP2 bridge
passes through the ingressed furrow.
(D) Aurora B-EGFP localized to a ring (arrowheads)
in interphase HeLa cell stably expressing H2B-
mCherry and Aurora B-EGFP.
(E and F) Dynamic association of Aurora B with the
ring. (E) HeLa cells expressing mRFP-LAP2b and
Aurora B-EGFP were photobleached in regions
as indicated by the dashed circle. Open arrow-
heads mark the position where the ring previously
localized, immediately after photobleaching
(0 min) and after 45 min. (F) Quantitation of fluores-
cence recovery in the bleached region. Time point
0 corresponds to the frame immediately after
photobleaching. Data are mean ± SEM (n = 7).
(G and H) Nuclear-cytoplasmic shuttling of
Aurora B. (G) Repetitive photobleaching of Aurora
B-EGFP in cytoplasmic regions (dashed area) of
HeLa cells stably coexpressing Aurora B-EGFP
and H2B-mCherry also depleted Aurora B-EGFP
fluorescence both in the cytoplasm (blue circle),
and in the nucleus (red circle). Nuclear fluores-
cence of Aurora B-EGFP in a neighboring cell
(white circle) remained constant. (H) Quantification
of fluorescence in regions similar to those indi-
cated in (G). The mean normalized to the pre-
bleach frame from seven experiments is plotted.
(I) Aurora B inhibition during telophase causes tet-
raploidization in chromosome bridge-containing
cells. H2B-mRFP and MyrPalm-mEGFP express-
ing HeLa cells were scored for chromosome
bridges during anaphase (compare Figure 1A),
and treated with DMSO (Control), Hesperadin, or
ZM1 in telophase (t = 0). Cleavage furrow regres-
sion (CFR) was detected during subsequent
15 hr time-lapse recording.
Scale bars represent 10 mm.
ingressed furrow in chromosome bridge-
containing posttelophase cells.
DISCUSSION
Our study provides first evidence that
abscission timing in animal cells depends
on the completion of chromosome segre-
gation, which is necessary to prevent tetraploidization by furrow
regression.
Our data support the view that chromatin trapped in the
cleavage plane is themajor cause for spontaneous tetraploidiza-
tion in cultured cells (Weaver et al., 2006). However, we found
that most cells with chromosome bridges suppressed furrow
regression and continued to proliferate normally. Our studyCell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc. 481
Figure 7. Aurora B-Dependent Phosphory-
lation and Stabilization of Mklp1
(A and B) Aurora B-dependent phosphorylation of
Mklp1. Immunofluorescence in HeLa cells stably
expressing mRFP-a-tubulin to validate by disas-
sembled midbody microtubules that cells were in
interphase. Chromosome bridges were detected
by an antibody against LAP2. Antibodies detecting
Mklp1, and phospho-S911-Mklp1 were used as
indicated. (A) Cells were synchronized by mitotic
shake-off, and fixed after 3 hr. (B) Cells were
treated with ZM1 15 min after mitotic shake-off
and fixed after 3 hr.
(C and D) Aurora B inhibition destabilizes Mklp1-
YFP at stable cytoplasmic canals in cells with
chromosome bridges. (C) HeLa cells expressing
H2B-mCherry and Mklp1-YFP were scored for
chromosome bridges in anaphase. ZM1 was
added after complete furrow ingression (0 min),
and cells were followed by time-lapse imaging.
(D) Quantitation of mean Mklp1-YFP fluorescence
at the ring in cells treated with ZM1 as in (C), or
DMSO-treated control cells. Mean ± SEM of 14
(ZM1), or 10 (Control) cells is plotted.
(E–G) Model for the function and regulation of
Aurora B in cells with chromosome bridges. Active
states are highlighted in yellow. (E) The presence
of a chromosome bridge sustains Aurora B activity
to posttelophase stages, which leads to Mklp1
phosphorylation, stabilization of the intercellular
canal, and delays abscission. (F) Resolution of
chromosomebridge leads to removal of chromatin
from the cleavage site, and inactivation of
Aurora B. This destabilizes the intercellular canal
and leads to abscission. (G) Chemical inhibition
of Aurora B in the presence of a chromosome
bridge destabilizes the intercellular canal and
leads to tetraploidization by furrow regression.
Scale bars represent 10 mm.provides a mechanistic explanation for this: these missegregat-
ing cells stabilized the ingressed furrow and delayed abscission
to posttelophase stages. Removal of chromosome bridges
either by spontaneous resolution or by laser microsurgery
resulted in rapid abscission. On the other hand, when abscission
was mechanically blocked by asbestos fibers cells did not main-
tain an ingressed furrow during interphase. Together, this
suggests a specific signal provided by chromatin at the cleavage
site to stabilize the ingressed furrow for delayed abscission.
Our data lead us to propose a model with Aurora B as a key
regulator of abscission timing, which responds to unsegregated
chromatin (Figures 7E–7G). Aurora B inactivation probably
involving dephosphorylation by a yet unknown mechanism nor-
mally promotes abscission about one hour after anaphase onset.
The presence of chromosome bridges prevents Aurora B inacti-
vation, and leads to its re-localization to a narrow ring at the inter-
cellular canal upon midbody disassembly. This stabilizes the
intercellular canal for delayed abscission. Premature inactivation
of Aurora B in cells with chromosome bridges leads to furrow
regression, likely due to premature destabilization of the intercel-
lular canal at a stage that is not yet compatible with abscission.482 Cell 136, 473–484, February 6, 2009 ª2009 Elsevier Inc.Aurora B phosphorylation at intercellular canals does not
exclusively depend on its auto-activation, since inhibition of
Aurora B at this stage did not completely remove phospho-
T232 at intercellular canals. This predicts that Aurora B could
be activated by additional kinases, putatively localized on
unsegregated chromatin at the cleavage site. Alternatively,
chromosome bridges could counteract dephosphorylation of
Aurora B by inhibitory phosphatases. Either possibility would
provide an intriguing explanation how Aurora B could function
in a chromatin sensor. Recent in vitro studies demonstrated
that Aurora B can be regulated by chromatin (Kelly et al., 2007;
Rosasco-Nitcher et al., 2008). Because ring-localized Aurora B
can access chromatin by nuclear-cytoplasmic shuttling, this
mayprovide a startingpoint to investigate themechanistic details
how chromosome bridges could sustain Aurora B activity.
Consistent with previous studies on earlier cytokinetic stages
(Neef et al., 2006), we found that Aurora B phosphorylates S911
of Mklp1 at the stable cytoplasmic canal connecting posttelo-
phase sister cells, and active Aurora B was required to maintain
stable levels of Mklp1 at this localization. Based on the proposed
function of Mklp1 to stabilize the midbody and anchor the
ingressed furrow during telophase (Guse et al., 2005), it is
conceivable to speculate that Mklp1 could also contribute to
the stability of the posttelophase canal. It will be interesting to
test this once time-controlled perturbation of Mklp1 becomes
possible, e.g., by specific small molecule inhibitors.
The abscission delay in response to chromosome segregation
errors by Aurora B-like kinases is evolutionary conserved in
budding yeast ((Norden et al., 2006) and Y. Barral and M. Men-
doza, personal communication). In contrast to yeast, the main
function of the abscission delay in human cells is to prevent tet-
raploidization, rather than chromosome breakage. This suggests
that themammalian abscissionmachinery is incapable of cutting
through chromatin, whichmight be due to the lack of a stabilizing
septum or the higher condensation state of human chromo-
somes as compared to their yeast counterparts.
In conclusion, our study defines a new regulatory mechanism
for abscission in animal cells that prevents tetraploidization by
furrow regression in response to chromosome segregation
defects. At an estimated incidence of chromosome bridges in
normal somatic tissues of about 1% (Cimini et al., 2003;
Gisselsson et al., 2000), this likely is an essential requirement
for organismal development. Because of the oncogenic potential
of tetraploidization (Fujiwara et al., 2005; Ganem et al., 2007), it
could also reduce the risk of cancer in aging tissues, where the
incidence of chromosome bridges increases due to telomere
attrition (Chin et al., 2004; Maser and DePinho, 2002; Stewenius
et al., 2005). However, how tetraploidization of individual cells
contributes to aneuploidy in cell populations and cancer forma-
tion will need further thorough investigation. Aurora B has
recently received significant attention as a potential target for
anti-cancer drugs. A better understanding of the cellular
processes controlled by Aurora B thus contributes to optimize
the efficiency and specificity of cytostatic treatments.
EXPERIMENTAL PROCEDURES
Cell Lines and Plasmids
HeLa, hTERT-RPE1, and NRK cells were cultured in DMEM (GIBCO) supple-
mented with 10% fetal calf serum (PAA Laboratories) and 1% Penicillin/Step-
tomycin (Invitrogen), and grown on LabTek chambered coverslips (Nunc) for
live microscopy. All live imaging experiments using HeLa or hTERT-RPE1 cells
were performed with monoclonal cell lines stably expressing combinations of
the fluorescent markers as indicated throughout the manuscript (complete
lists of plasmids and cell lines see Tables S1 and S2).
Microscopy and Image Analysis
Confocal live imaging was on a customized Zeiss LSM 510 Axiovert micro-
scope using a 633, 1.4 N.A. Oil Plan-Apochromat or 403, 1.3 N.A. Oil EC
Plan-Neofluar objective (Zeiss), or on a Zeiss Axiovert equippedwith a VisiTech
Spinning disk and Hamamatsu ORCA ER camera and a 1003, 1.4 N.A. Oil
Plan-Apochromat objective (Zeiss). Both microscopes were equipped with
piezo focus drives (piezosystemjena), custom-designed filters (Chroma), and
EMBL incubation chambers (European Molecular Biology Laboratory),
providing a humidified atmosphere at 37C with 5% CO2. Long-term movies
for Figures 1B–1E were acquired on a Molecular Devices ImageXpressMicro
microscope, equipped with incubation chamber (37C, humidified, 5% CO2)
and a 103, 0.5 N.A. S Fluor objective (Nikon). Sample illumination was gener-
ally kept to a minimum and had no adverse effect on cell division and prolifer-
ation. Image analysis was by Zeiss LSM510 and ImageJ software. Linear
contrast adjustments were applied with constant settings for different experi-
mental conditions. For quantification of antibody stainings, 3D image stackswere projected by mean fluorescence intensity. Background-subtracted
intensity was then measured in a region of constant size centered around
the peak fluorescence signal at midbodies, or chromosome bridges.
Photoactivation and Photobleaching
For experiments shown in Figures 2C and 2D, S2 and 5E, PAGFP was acti-
vated by radiating a defined region with 30 mW 405 nm diode laser at 100%
transmission. Activation of PAGFP on the PALM microscope (Figures 2F–
2H) was by UV epifluorescence illumination through the closed field aperture
for about 1 s. FRAP experiments used 50 iterations of photobleaching at
100% transmission of 488 nm laser at regions similar to the one indicated in
Figure 6E. Recovery kinetics of mean fluorescence intensity were measured
in a region of constant size at the location of the Aurora B ring, and after back-
ground subtraction were normalized to pre- and first postbleach frame. Fluo-
rescence loss in photobleaching experiments used 20 iterations of photo-
bleaching at 100% transmission of 488 nm laser at regions similar to the one
indicated in Figure 6G before acquisition of each time point. Mean fluores-
cence was measured in regions of constant size as indicated in Figure 6G,
and after background subtraction normalized to the prebleach frame.
Laser Microsurgery
Intracellular Microsurgery was performed on a PALM MicroLaser System
(Zeiss) equipped with a pulsed 355 nm UV-A laser using a 100 3 1.3NA Oil
DICIII EC Plan NeoFluar objective (Zeiss). The microsurgery protocol was
applied by focused laser illumination during linear stage movement as high-
lighted in the respective Figs. The following parameters were set: 45% laser
energy, 63% laser focus, 14% cut speed. Cells exposed to laser microsurgery
were viable at least 2 hr after microsurgery, tested by DIC imaging.
Inhibitor and Asbestos Treatments
For immunofluorescence inhibitors were added directly after mitotic shake-off
and the cells were fixed and stained after 2–3 hr incubation. For time-lapse
imaging experiments inhibitors were added during telophase. DMSO
(Sigma-Aldrich), Hesperadin (kind gift of N. Kraut, Boehringer Ingelheim, final
concentration: 100 nM), ZM1 (Tocris, final concentration: 2–4 mM), RO-3306
(Calbiochem, final concentration: 30 mM), and SB203580 (Calbiochem, final
concentration: 10 mM) were dissolved in prewarmed culture medium to 10x
solutions, and added to their final concentrations. Crocidolite (UICC Asbestos
Standards) fibers of 90-260 nm diameter (spi supplies, USA; (Pelin et al., 1992))
were added to the cell at a final concentration of 5 mg/cm2 followed by incuba-
tion for 12–24 hr.
Immunofluorescence Staining
Immunofluorescence and phalloidin stainings were by standard methods after
formaldehyde or methanol fixation. Mouse anti-LAP2 (BD Transduction Labo-
ratories), rabbit anti-Mklp1 (Santa Cruz Biotechnology), rabbit anti-phospho-
S911-Mklp1 (kind gift from F. Barr), rabbit anti-Aurora B (kind gift of P.Meraldi),
rabbit anti- phospho-T232-Aurora B (Rockland), and rabbit anti-INCENP
(Abcam) were used as primary antibodies, and appropriate secondary anti-
bodies conjugated with either Alexa-Fluor 405, Alexa-Fluor 488, Alexa-Fluor
546 or Alexa-Fluor 633 (Invitrogen) were used. Actin was visualized by incuba-
tion with 5 U/ml Alexa Fluor 546 or 488 Phalloidin (Invitrogen) for 1 hr.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, two
tables, six figures, Supplemental References, and fifteen movies and can
be found with this article online at http://www.cell.com/supplemental/
S0092-8674(08)01601-2.
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